Form 8-K - Current report:
SEC Accession No. 0001193125-26-177406
Filing Date
2026-04-24
Accepted
2026-04-24 16:30:20
Documents
9
Period of Report
2026-04-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K nams-20260420.htm   iXBRL 8-K 53761
  Complete submission text file 0001193125-26-177406.txt   202720

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT nams-20260420.xsd EX-101.SCH 55020
12 EXTRACTED XBRL INSTANCE DOCUMENT nams-20260420_htm.xml XML 6274
Mailing Address GOOIMEER 2-35 NARRDEN P7 1411 DC
Business Address GOOIMEER 2-35 NARRDEN P7 1411 DC 35 206 2971
NewAmsterdam Pharma Co N.V. (Filer) CIK: 0001936258 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41562 | Film No.: 26894759
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)